Angioplasty Balloons Market Report by Product Type, Application, Material, End-User, and Region 2024-2032
세계의 혈관성형술용 풍선 시장 규모는 2023년 24억 달러에 달했습니다. 향후 IMARC Group은 2024년부터 2032년까지의 복합 연간 성장률(CAGR)은 2.8%를 나타낼 전망이며 2032년에는 32억 달러에 달할 것으로 예측했습니다.
혈관성형술용 풍선이란 외과 수술 시 막힌 혈관을 제거하고 펼치는 데 사용되는 의료기기를 말합니다. 일반적인 혈관 성형술 풍선에는 약물 용출 풍선, 정상 풍선, 점수 풍선, 절단 풍선 등이 있습니다. 일반적으로 나일론, 폴리우레탄 및 실리콘 우레탄 폴리머를 사용하여 제조되며, 니티놀로 만들어진 구속 구조는 풍선 표면에 홈과 베개를 형성하여 예측 가능하고 균일하고 외관적인 확장을 제공합니다. 수술은 풍선을 부풀려 플라크를 혈관 벽에 밀어 넣고 혈관을 열어 정상적인 혈류를 회복시킵니다.
전 세계적으로 관상 동맥 및 말초 동맥 질환의 유병률이 증가하고 있다는 것이 시장 성장을 가속하는 주요 요인 중 하나입니다. 이에 따라 노년 인구와 비만, 높은 콜레스테롤 수치를 앓고 있는 사람들 증가도 시장 성장을 뒷받침하고 있습니다. 게다가 안전성과 효능이 뛰어나 전신의 혈류를 개선하는 약제 코팅 혈관 성형술용 풍선에 대한 기호가 높아지고 있습니다. 이러한 이유로 혈관 파괴를 일으킬 수 있는 스텐트와 같은 혈관 임플란트의 사용도 감소하고 있습니다. 게다가 이미징 기술의 개발이나 전신 마취를 들이지 않고 이식할 수 있는 혁신적인 변형의 등장 등 다양한 기술의 진보도 큰 성장 촉진요인으로 작용하고 있습니다. 소비자의 건강 의식 증가, 의료 인프라 개선, 의료 과학 분야의 광범위한 R&D 활동은 시장을 더욱 견인할 것으로 예상되는 기타 요인의 일부입니다.
이 보고서에서 다루는 주요 질문
- 세계의 혈관성형술용 풍선 시장은 지금까지 어떻게 추이해, 향후 어떻게 추이해 갈 것인가?
- 주요 지역 시장은?
- COVID-19는 세계의 혈관 성형술 풍선 시장에 어떤 영향을 미쳤는가?
- 제품 유형별 시장 분석은?
- 용도별 시장 분석은?
- 소재별 시장 분석은?
- 최종 사용자별 시장 분석은?
- 업계의 밸류체인의 다양한 단계란?
- 업계의 주요 촉진요인과 도전은 무엇인가?
- 세계의 혈관 성형술 풍선 시장의 구조와 주요 기업는?
- 업계 경쟁도는?
목차
제1장 서문
제2장 조사 범위와 조사 방법
- 조사의 목적
- 이해관계자
- 데이터 소스
- 시장 추정
- 조사 방법
제3장 주요 요약
제4장 소개
제5장 세계의 혈관성형술용 풍선 시장
- 시장 개요
- 시장 실적
- COVID-19의 영향
- 시장 예측
제6장 시장 내역 : 제품 유형별
- 일반 풍선
- 풍선을 자르는
- 약제 용출 풍선
- 스코어링 풍선
제7장 시장 분석 : 용도별
제8장 시장 분석 : 재료별
- 나일론
- 폴리우레탄
- 실리콘 우레탄 공중합체
- 기타
제9장 시장 내역 : 최종 사용자별
제10장 시장 내역 : 지역별
- 북미
- 아시아태평양
- 유럽
- 독일
- 프랑스
- 영국
- 이탈리아
- 스페인
- 러시아
- 기타
- 라틴아메리카
- 중동 및 아프리카
제11장 SWOT 분석
제12장 밸류체인 분석
제13장 Porter's Five Forces 분석
- 개요
- 구매자의 협상력
- 공급기업의 협상력
- 경쟁도
- 신규 참가업체의 위협
- 대체품의 위협
제14장 가격 지표
제15장 경쟁 구도
- 시장 구조
- 주요 기업
- 주요 기업 프로파일
- Abbott Laboratories
- B. Braun Melsungen AG
- BD(Becton, Dickinson and Company)
- Biotronik SE & Co. KG
- Boston Scientific Corporation
- Cardinal Health Inc.
- Cook Medical LLC
- Endocor GmbH & Co. KG
- Johnson & Johnson
- Medtronic Inc.
- Terumo Corporation
BJH
The global angioplasty balloons market size reached US$ 2.4 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 3.2 Billion by 2032, exhibiting a growth rate (CAGR) of 2.8% during 2024-2032.
Angioplasty balloons refer to the medical devices that are used for unblocking and widening clogged blood vessels during surgical procedures. Some of the common types of angioplasty balloons include drug-eluting, normal, scoring and cutting balloons. They are usually manufactured using nylon, polyurethane and silicone urethane polymers and consist of nitinol constraining structures that create grooves and pillows on the surface of the balloon to offer predictable, uniform and atraumatic dilation. During the surgery, the balloon is inflated to flatten the plaque against the wall of the blood vessels, thereby opening them and restoring the normal blood flow.
The increasing prevalence of coronary and periphery artery diseases across the globe is one of the key factors driving the growth of the market. In line with this, the rising geriatric population and individuals suffering from obesity and high levels of cholesterol are also providing a boost to the market growth. Furthermore, there is an increasing preference for drug-coated angioplasty balloons that offer superior safety, effectiveness and improved blood flow throughout the body. This has also reduced the utilization of vessel implants, such as stents, which may cause vessel fracture. Additionally, various technological advancements, such as the development of imaging technologies, and the advent of innovative variants that can be implanted without administering general anesthesia, are also acting as major growth-inducing factors. Increasing health consciousness among consumers, improving healthcare infrastructure and extensive research and development (R&D) activities in the field of medical sciences are some of the other factors that are projected to drive the market further.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global angioplasty balloons market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on product type, application, material and end-user.
Breakup by Product Type:
Normal Balloons
Cutting Balloons
Drug Eluting Balloons
Scoring Balloons
Breakup by Application:
Coronary Angioplasty
Peripheral Angioplasty
Breakup by Material:
Nylon
Polyurethane
Silicone Urethane Co-Polymers
Others
Breakup by End-User:
Hospitals
Ambulatory Surgery Centers
Others
Breakup by Region:
North America
United States
Canada
Asia Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
Competitive Landscape:
The report has also analysed the competitive landscape of the market with some of the key players being Abbott Laboratories, B. Braun Melsungen AG, BD (Becton, Dickinson, and Company), Biotronik SE & Co. KG, Boston Scientific Corporation, Cardinal Health Inc., Cook Medical LLC, Endocor GmbH & Co. KG, Johnson & Johnson, Medtronic Inc., Terumo Corporation, etc.
Key Questions Answered in This Report:
- How has the global angioplasty balloons market performed so far and how will it perform in the coming years?
- What are the key regional markets?
- What has been the impact of COVID-19 on the global angioplasty balloons market?
- What is the breakup of the market based on the product type?
- What is the breakup of the market based on the application?
- What is the breakup of the market based on the material?
- What is the breakup of the market based on the end-user?
- What are the various stages in the value chain of the industry?
- What are the key driving factors and challenges in the industry?
- What is the structure of the global angioplasty balloons market and who are the key players?
- What is the degree of competition in the industry?
Table of Contents
1 Preface
2 Scope and Methodology
- 2.1 Objectives of the Study
- 2.2 Stakeholders
- 2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
- 2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
- 2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
- 4.1 Overview
- 4.2 Key Industry Trends
5 Global Angioplasty Balloons Market
- 5.1 Market Overview
- 5.2 Market Performance
- 5.3 Impact of COVID-19
- 5.4 Market Forecast
6 Market Breakup by Product Type
- 6.1 Normal Balloons
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
- 6.2 Cutting Balloons
- 6.2.1 Market Trends
- 6.2.2 Market Forecast
- 6.3 Drug Eluting Balloons
- 6.3.1 Market Trends
- 6.3.2 Market Forecast
- 6.4 Scoring Balloons
- 6.4.1 Market Trends
- 6.4.2 Market Forecast
7 Market Breakup by Application
- 7.1 Coronary Angioplasty
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
- 7.2 Peripheral Angioplasty
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
8 Market Breakup by Material
- 8.1 Nylon
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
- 8.2 Polyurethane
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
- 8.3 Silicone Urethane Co-Polymers
- 8.3.1 Market Trends
- 8.3.2 Market Forecast
- 8.4 Others
- 8.4.1 Market Trends
- 8.4.2 Market Forecast
9 Market Breakup by End-User
- 9.1 Hospitals
- 9.1.1 Market Trends
- 9.1.2 Market Forecast
- 9.2 Ambulatory Surgery Centers
- 9.2.1 Market Trends
- 9.2.2 Market Forecast
- 9.3 Others
- 9.3.1 Market Trends
- 9.3.2 Market Forecast
10 Market Breakup by Region
- 10.1 North America
- 10.1.1 United States
- 10.1.1.1 Market Trends
- 10.1.1.2 Market Forecast
- 10.1.2 Canada
- 10.1.2.1 Market Trends
- 10.1.2.2 Market Forecast
- 10.2 Asia Pacific
- 10.2.1 China
- 10.2.1.1 Market Trends
- 10.2.1.2 Market Forecast
- 10.2.2 Japan
- 10.2.2.1 Market Trends
- 10.2.2.2 Market Forecast
- 10.2.3 India
- 10.2.3.1 Market Trends
- 10.2.3.2 Market Forecast
- 10.2.4 South Korea
- 10.2.4.1 Market Trends
- 10.2.4.2 Market Forecast
- 10.2.5 Australia
- 10.2.5.1 Market Trends
- 10.2.5.2 Market Forecast
- 10.2.6 Indonesia
- 10.2.6.1 Market Trends
- 10.2.6.2 Market Forecast
- 10.2.7 Others
- 10.2.7.1 Market Trends
- 10.2.7.2 Market Forecast
- 10.3 Europe
- 10.3.1 Germany
- 10.3.1.1 Market Trends
- 10.3.1.2 Market Forecast
- 10.3.2 France
- 10.3.2.1 Market Trends
- 10.3.2.2 Market Forecast
- 10.3.3 United Kingdom
- 10.3.3.1 Market Trends
- 10.3.3.2 Market Forecast
- 10.3.4 Italy
- 10.3.4.1 Market Trends
- 10.3.4.2 Market Forecast
- 10.3.5 Spain
- 10.3.5.1 Market Trends
- 10.3.5.2 Market Forecast
- 10.3.6 Russia
- 10.3.6.1 Market Trends
- 10.3.6.2 Market Forecast
- 10.3.7 Others
- 10.3.7.1 Market Trends
- 10.3.7.2 Market Forecast
- 10.4 Latin America
- 10.4.1 Brazil
- 10.4.1.1 Market Trends
- 10.4.1.2 Market Forecast
- 10.4.2 Mexico
- 10.4.2.1 Market Trends
- 10.4.2.2 Market Forecast
- 10.4.3 Others
- 10.4.3.1 Market Trends
- 10.4.3.2 Market Forecast
- 10.5 Middle East and Africa
- 10.5.1 Market Trends
- 10.5.2 Market Breakup by Country
- 10.5.3 Market Forecast
11 SWOT Analysis
- 11.1 Overview
- 11.2 Strengths
- 11.3 Weaknesses
- 11.4 Opportunities
- 11.5 Threats
12 Value Chain Analysis
13 Porters Five Forces Analysis
- 13.1 Overview
- 13.2 Bargaining Power of Buyers
- 13.3 Bargaining Power of Suppliers
- 13.4 Degree of Competition
- 13.5 Threat of New Entrants
- 13.6 Threat of Substitutes
14 Price Indicators
15 Competitive Landscape
- 15.1 Market Structure
- 15.2 Key Players
- 15.3 Profiles of Key Players
- 15.3.1 Abbott Laboratories
- 15.3.1.1 Company Overview
- 15.3.1.2 Product Portfolio
- 15.3.1.3 Financials
- 15.3.1.4 SWOT Analysis
- 15.3.2 B. Braun Melsungen AG
- 15.3.2.1 Company Overview
- 15.3.2.2 Product Portfolio
- 15.3.2.3 Financials
- 15.3.2.4 SWOT Analysis
- 15.3.3 BD (Becton, Dickinson and Company)
- 15.3.3.1 Company Overview
- 15.3.3.2 Product Portfolio
- 15.3.3.3 Financials
- 15.3.3.4 SWOT Analysis
- 15.3.4 Biotronik SE & Co. KG
- 15.3.4.1 Company Overview
- 15.3.4.2 Product Portfolio
- 15.3.4.3 Financials
- 15.3.4.4 SWOT Analysis
- 15.3.5 Boston Scientific Corporation
- 15.3.5.1 Company Overview
- 15.3.5.2 Product Portfolio
- 15.3.5.3 Financials
- 15.3.5.4 SWOT Analysis
- 15.3.6 Cardinal Health Inc.
- 15.3.6.1 Company Overview
- 15.3.6.2 Product Portfolio
- 15.3.6.3 Financials
- 15.3.6.4 SWOT Analysis
- 15.3.7 Cook Medical LLC
- 15.3.7.1 Company Overview
- 15.3.7.2 Product Portfolio
- 15.3.7.3 SWOT Analysis
- 15.3.8 Endocor GmbH & Co. KG
- 15.3.8.1 Company Overview
- 15.3.8.2 Product Portfolio
- 15.3.8.3 Financials
- 15.3.9 Johnson & Johnson
- 15.3.9.1 Company Overview
- 15.3.9.2 Product Portfolio
- 15.3.9.3 Financials
- 15.3.9.4 SWOT Analysis
- 15.3.10 Medtronic Inc.
- 15.3.10.1 Company Overview
- 15.3.10.2 Product Portfolio
- 15.3.11 Terumo Corporation
- 15.3.11.1 Company Overview
- 15.3.11.2 Product Portfolio
- 15.3.11.3 Financials
- 15.3.11.4 SWOT Analysis
